Concepts on Quantitative Risk Assessment of Neurotoxicants

[1]  K. Tipton,et al.  Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds , 1993, Journal of neurochemistry.

[2]  R L Kodell,et al.  Upper confidence limits on excess risk for quantitative responses. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[3]  E. Cadenas,et al.  MPP+ Redox Cycling: A New Mechanism Involving Hydride Transfer , 1992, Annals of the New York Academy of Sciences.

[4]  D W Gaylor,et al.  Incidence of developmental defects at the no observed adverse effect level (NOAEL). , 1992, Regulatory toxicology and pharmacology : RTP.

[5]  J. Sullivan,et al.  The neurotoxicity of MPTP and the relevance to Parkinson's disease. , 1990, Pharmacology & toxicology.

[6]  J. Parisi,et al.  Effects of l‐Methyl‐4‐Phenyl‐l,2,3,6‐Tetrahydropyridine in the Dog: Effect of Pargyline Pretreatment , 1989, Journal of neurochemistry.

[7]  D. Barnes,et al.  Reference dose (RfD): description and use in health risk assessments. , 1988, Regulatory toxicology and pharmacology : RTP.

[8]  P. Sonsalla,et al.  Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse. , 1987, The Journal of pharmacology and experimental therapeutics.

[9]  J. Langston,et al.  Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra , 1987, Brain Research.

[10]  K S Crump,et al.  A new method for determining allowable daily intakes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[11]  W. Beyer.  Handbook of Tables for Probability and Statistics , 1967 .

[12]  Ralph L. Kodell,et al.  Statistical methods of risk assessment for continuous variables , 1993 .

[13]  David W. Gaylor,et al.  Dose-response modeling of quantitative response data for risk assessment , 1992 .

[14]  J. Johannessen.  A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons. , 1991, Neurotoxicology.

[15]  W Slikker,et al.  Risk assessment for neurotoxic effects. , 1990, Neurotoxicology.

[16]  Kopin Ij.  Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals. , 1987 .